{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T10:19:20Z","timestamp":1770459560247,"version":"3.49.0"},"reference-count":111,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1517\/17425255.2012.708023","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T02:25:51Z","timestamp":1350527151000},"page":"1247-1261","source":"Crossref","is-referenced-by-count":5,"title":["ADMET considerations for restless leg syndrome drug treatments"],"prefix":"10.1517","volume":"8","author":[{"given":"Stefano","family":"de Biase","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Santa Maria della Misericordia University Hospital"},{"name":"Department of Experimental and Clinical Medicine, University of Udine Medical School","place":["Italy"]},{"name":"Center of Sleep Medicine, Neurology Unit, University of Udine","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Merlino","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Santa Maria della Misericordia University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Lorenzut","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Santa Maria della Misericordia University Hospital"},{"name":"Department of Experimental and Clinical Medicine, University of Udine Medical School","place":["Italy"]},{"name":"Center of Sleep Medicine, Neurology Unit, University of Udine","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Santa Maria della Misericordia University Hospital"},{"name":"Department of Experimental and Clinical Medicine, University of Udine Medical School","place":["Italy"]},{"name":"Center of Sleep Medicine, Neurology Unit, University of Udine","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luigi","family":"Gigli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Santa Maria della Misericordia University Hospital"},{"name":"Department of Experimental and Clinical Medicine, University of Udine Medical School","place":["Italy"]},{"name":"Center of Sleep Medicine, Neurology Unit, University of Udine","place":["Italy"]},{"name":"Professor, Director of Neurology, University of Udine Medical School, Department of Experimental and Clinical Medicine","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,7,18]]},"reference":[{"key":"e_1_3_1_3_1","volume-title":"International classification of sleep disorders. Diagnostic and coding manual","year":"2005","unstructured":"International classification of sleep disorders. Diagnostic and coding manual. 2nd edition. American Academy of Sleep Medicine; Westchester, IL: 2005","edition":"2"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70139-3"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.2.300"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004691-200103000-00004"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-007-0736-x"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22274"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(99)00012-X"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng2099"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.8.1698"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2004.01.014"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.7.866"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.5665\/sleep\/31.7.944"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000138427.83574.A6"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afi066"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.11.1286"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90136-1"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21545"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4547(20001201)62:5<623::AID-JNR1>3.0.CO;2-H"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241040-00003"},{"key":"e_1_3_1_22_1","volume-title":"Basic & clinical pharmacology","author":"Katzung G","year":"2007","unstructured":"Katzung G. Basic & clinical pharmacology. McGraw-Hill; New York, US:2007"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/242463a0"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(72)90456-1"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02571.x"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199614050-00006"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.2.445"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.suppl_1.S87"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/19.3.205"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2003.09.005"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01410.x"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10503"},{"key":"e_1_3_1_33_1","article-title":"Sleep-related movement disorders","author":"Merlino G","year":"2011","unstructured":"Merlino G, Gigli GL. Sleep-related movement disorders. Neurol Sci 2011. [Epub ahead of print]","journal-title":"Neurol Sci"},{"key":"e_1_3_1_34_1","unstructured":"REQUIP: Prescribing Information. Available from: http:\/\/www. requip.com [Last accessed 11 March 2012]"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702673"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.3_Suppl_3.S6"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.12.010"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.2147\/nedt.S24407"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01025.x"},{"key":"e_1_3_1_40_1","first-page":"1211","article-title":"Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen","volume":"25","author":"Wynalda MA","year":"1997","unstructured":"Wynalda MA, Wienkers LC. Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen. Drug Metab Dispos 1997;25:1211-14","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701791"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.3.255"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24889"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.9.noc50009"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-117"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2005.01.001"},{"key":"e_1_3_1_47_1","unstructured":"MIRAPEX: Prescribing Information. Available from: http:\/\/www. mirapexer.com [Last accessed 16 March 2012]"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.08.004"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04330.x"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00307-4"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.2.225"},{"key":"e_1_3_1_52_1","first-page":"1211","article-title":"Assessment of potential interactions between dopamine receptor agonists and various humas cytochrome P450 enzymes using a simple in vitro inhibition screen","volume":"25","author":"Wynalda MA","year":"1997","unstructured":"Wynalda MA, Wienkers LC. Assessment of potential interactions between dopamine receptor agonists and various humas cytochrome P450 enzymes using a simple in vitro inhibition screen. Drug Metab Dispos 1997;25:1211-14","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_1_53_1","first-page":"182","article-title":"The population pharmacokinetics of pramipexole in Parkinson's disease patients","volume":"61","author":"Wright CE","year":"1997","unstructured":"Wright CE, Grasela TH, Phillips L. The population pharmacokinetics of pramipexole in Parkinson's disease patients. Clin Pharmacol Ther 1997;61:182","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000231513.23919.a1"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2006.10.001"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(02)00144-2"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/26.7.819"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2010.11.002"},{"key":"e_1_3_1_59_1","unstructured":"NEUPRO: Prescribing Information. Available from: http:\/\/www. neupro.com [Last accessed 19 March 2012]"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s3675"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746100-00003"},{"issue":"2","key":"e_1_3_1_62_1","first-page":"96","article-title":"Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's disease","volume":"12","author":"Braun M","year":"2005","unstructured":"Braun M, Cawello W, Poole K, Steady-state pharmacokinetics of rotigotine in patients with early-stage Parkinson's disease. Eur J Neurol 2005;12(Suppl 2):96","journal-title":"Eur J Neurol"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.143"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285610374679"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/18.2.71"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2010.46.7.1463530"},{"issue":"1","key":"e_1_3_1_67_1","first-page":"262","article-title":"Transdermal rotigotine results in suitable pharmacokinetic properties for various patients subpopulations","volume":"24","author":"Elshoff JP","year":"2009","unstructured":"Elshoff JP, Cawello W, Horstmann R, Transdermal rotigotine results in suitable pharmacokinetic properties for various patients subpopulations. Mov Disord 2009;24(Suppl 1):262","journal-title":"Mov Disord"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04053.x"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.04.012"},{"issue":"3","key":"e_1_3_1_70_1","first-page":"110","article-title":"Augmentation in the therapy of restless legs syndrome with transdermal rotigotine: a retrospective systematic analysis of two large double-blind 6-month trials","volume":"15","author":"Garcia-Borreguero D","year":"2008","unstructured":"Garcia-Borreguero D, Ferini-Strambi L, Kohnen R. Augmentation in the therapy of restless legs syndrome with transdermal rotigotine: a retrospective systematic analysis of two large double-blind 6-month trials. Eur J Neurol 2008;15(Suppl 3):110","journal-title":"Eur J Neurol"},{"issue":"1","key":"e_1_3_1_71_1","first-page":"438","article-title":"Augmentation in long-term therapy of the restless legs syndrome with transdermal rotigotine - a retrospective systematic analysis of two large open-label 1-year trials","volume":"24","author":"Benes H","year":"2009","unstructured":"Benes H, Garcia-Borreguero D, Allen R, Augmentation in long-term therapy of the restless legs syndrome with transdermal rotigotine - a retrospective systematic analysis of two large open-label 1-year trials. Mov Disord 2009;24(Suppl 1):438","journal-title":"Mov Disord"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70127-2"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21401"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000124465.20878.84"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285610378059"},{"key":"e_1_3_1_76_1","unstructured":"HORIZANT: Prescribing Information. Available from: http:\/\/www. horizant.com [Last accessed 26 March 2012]"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22254"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018951214146"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.067959"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008322909"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S5712"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.12.004"},{"key":"e_1_3_1_83_1","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1528-1157.1995.tb06001.x","article-title":"Gabapentin","volume":"36","author":"McLean MJ","year":"1995","unstructured":"McLean MJ. Gabapentin. Epilepsia 1995;36:S57-86","journal-title":"Epilepsia"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.07.026"},{"key":"e_1_3_1_85_1","unstructured":"LYRICA: Prescribing Information. Available from: http:\/\/www.lyrica.com [Last accessed 30 March 2012]"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009352087"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.2165\/11536200-000000000-00000"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00251.x"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003251119"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2010.03.003"},{"key":"e_1_3_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2004.01.012"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.09.007"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1596"},{"key":"e_1_3_1_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.12.003"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4666"},{"key":"e_1_3_1_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2005.01.008"},{"key":"e_1_3_1_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.06.009"},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.11.021"},{"key":"e_1_3_1_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22562"},{"key":"e_1_3_1_100_1","article-title":"Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study","author":"Wang J","year":"2009","unstructured":"Wang J, O'Reilly B, Venkataraman R, Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study. Sleep Med 2009; Ahead of print","journal-title":"Sleep Med"},{"key":"e_1_3_1_101_1","volume-title":"Rang and Dale's pharmacology","author":"Rang HP","year":"2007","unstructured":"Rang HP, Dale MM, Ritter JM, Flower RJ. Rang and Dale's pharmacology. Churcill Livingstone Elsevier; Philadelphia, US:2007"},{"key":"e_1_3_1_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2007.11.020"},{"key":"e_1_3_1_103_1","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder C","year":"2004","unstructured":"Trenkwalder C, Garcia-Borreguero D, Montagna P, Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004;75:92-7","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_104_1","first-page":"91","article-title":"Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome","volume":"10","author":"Merlino G","year":"2009","unstructured":"Merlino G, Serafini A, Young JJ, Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome. Curr Opin Investig Drugs 2009;10:91-102","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_1_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2003.07.005"},{"key":"e_1_3_1_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21545"},{"key":"e_1_3_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(09)70838-7"},{"key":"e_1_3_1_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01459.x"},{"key":"e_1_3_1_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2006.09.009"},{"key":"e_1_3_1_110_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666050-00003"},{"key":"e_1_3_1_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22955"},{"key":"e_1_3_1_112_1","article-title":"Family recurrence and oligo-anuria predict uremic restless legs syndrome","author":"Pizza F","year":"2011","unstructured":"Pizza F, Persici E, La Manna G, Family recurrence and oligo-anuria predict uremic restless legs syndrome. Acta Neurol Scand 2011. [Epub ahead of print]","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_113_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp125"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17425255.2012.708023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:05:52Z","timestamp":1770393952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17425255.2012.708023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,18]]},"references-count":111,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1517\/17425255.2012.708023"],"URL":"https:\/\/doi.org\/10.1517\/17425255.2012.708023","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,18]]}}}